United States · Funded startup

Who invested in Tolera Therapeutics

6 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$12Mraised across 6 rounds since 2008, from 6 sources

$4.1MVenture$1.5MDebt$5.5MSeries B$1.1MDebt$250KDebt
Latest round
Debt, $250KSept 2014
Biggest round
$5.5MSeries B · Oct 2012
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

200920102011201220132014
?Series A$4.1MVenture$1.5MDebt$5.5MSeries B$1.1MDebt$250KDebt
First round
Series A
Jun 2008
Biggest round
$5.5M
Series B · Oct 2012
Usual gap between rounds
12 months
the median of 5

The rounds

  1. Sept 2014
    Debt$250K

    No investor was named in the report.

    From a historical funding recordSEC filing: $250K sold, first sale Sept 2014

  2. Oct 2013
    Debt$1.1M

    No investor was named in the report.

    Reported by sec.govSEC filing: $1.1M sold, first sale Sept 2013

  3. Oct 2012
    Series B$5.5M1 new2 returning

    Reported by prnewswire.comSEC filing: $5.4M sold, first sale Oct 2012

  4. May 2012
    Debt$1.5M

    No investor was named in the report.

    Reported by sec.govSEC filing: $1.5M sold, first sale May 2012

  5. Jun 2010
    Venture$4.1M

    No investor was named in the report.

    From a historical funding recordSEC filing: $4.1M sold, first sale May 2010

  6. Jun 2008
    Series AAmount undisclosed3 new

    From a historical funding record

Founders and team

From the SEC filings it signed: 1 on the team.

  • Ashleigh PalmerExecutive Officeri

On the board, as filediDonald ParfetDouglas MortonMark OlesnavageSuzette Dutch

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2008Venture2010Debt2012Series B2012Debt2013Debt2014Triathlon Medical Venture PartnersSouthwest Michigan FirstHopen Life Science VenturesHopen Therapeutics

Everyone who backed them

Southwest Michigan FirstInvestment firm2rounds
Hopen Therapeuticsno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Tolera Therapeutics

Who invested in Tolera Therapeutics?

Tolera Therapeutics's investors include Triathlon Medical Venture Partners, Southwest Michigan First, Hopen Life Science Ventures and Hopen Therapeutics.

How much has Tolera Therapeutics raised?

Tolera Therapeutics has raised $12M across 6 rounds since 2008. One round did not disclose an amount, so the total is a floor.

When did Tolera Therapeutics last raise?

Tolera Therapeutics's most recent round was a Debt of $250K in Sept 2014.

What was Tolera Therapeutics's biggest round?

Tolera Therapeutics's largest round on record is $5.5M (Series B), in Oct 2012.

Who backed Tolera Therapeutics first?

Tolera Therapeutics's first round on record, in Jun 2008, was backed by Triathlon Medical Venture Partners, Southwest Michigan First and Hopen Therapeutics.

What stage is Tolera Therapeutics at?

Tolera Therapeutics's latest named round is a Debt, in Sept 2014.

Where is Tolera Therapeutics based?

Tolera Therapeutics is based in the United States.

Companies like Tolera Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.